Mylan shares bounce 6% on plans for Botox copycat, 2018 drug launches
March 01, 2018 at 11:02 AM EST
The move allows Mylan to vie for one of rival Allergan’s most valuable assets.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.